Hydroxy pioglitazone (M-IV)
CAS: 146062-44-4
Rif. 3D-FH24088
1mg | 1.044,00 € | ||
2mg | 1.403,00 € | ||
5mg | 1.684,00 € | ||
250µg | 440,00 € | ||
500µg | 626,00 € |
Informazioni sul prodotto
- 5-[[4-[2-[5-(1-Hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione
- 5-[[4-[2-[5-(1-Hydroxyethyl)-2-Pyridinyl]Ethoxy] Phenyl]Methyl]-2,4-Thiazolidinedione
- Hydroxy Pioglitazone (M-IV)
- Pioglitazone, hydroxy M-IV
- 5-(4-{2-[5-(1-Hydroxyethyl)Pyridin-2-Yl]Ethoxy}Benzyl)-1,3-Thiazolidine-2,4-Dione
Hydroxy pioglitazone (M-IV) is a derivative of the antidiabetic agent pioglitazone. It is a hydroxy derivative that has been shown to inhibit mitochondrial fatty acid synthesis and increase mitochondrial membrane potential. This drug also inhibits the activity of enzymes involved in fatty acid synthesis, including the enzyme acetyl coenzyme A carboxylase, thereby reducing the production of fatty acids. The hydroxy derivative of pioglitazone has been shown to have an improved pharmacokinetic profile when compared with its parent compound.
Proprietà chimiche
Richiesta tecnica su: 3D-FH24088 Hydroxy pioglitazone (M-IV)
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.